Calliditas Therapeutics AB (publ) CALT
$ 40.0
-0.1%
Quarterly report 2022-Q2
added 08-19-2022
Country |
Schweden |
IPO year |
2020 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Renee Aguiar-Lucander |
Employees in the company |
23 |
Shares |
50.8 M |
Market Cap[1] |
$ 2.03 B |
EBITDA (LTM) |
$ -585 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.